64
Growth Score
pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
395242
Innomab is a dynamic high-performing drug-development team
- Kim Graham: Founder & Chief Executive Officer
- Kristine Chavez: Founder & Chief Operating Officer
About the Company
Innomab is a dynamic high-performing drug-development team dedicated to bridging the gap between today’s exciting molecular biology discoveries and patients' need for safer more effective drugs. Founded in 2008 by three San Francisco Bay Area drug development professionals, Innomab provides consulting services in support of promising new
drug candidate molecules from the late stages of laboratory research through early human clinical trials, at which point, these molecules may attract acquisition by large pharmaceutical companies.
Women Founded
